Efficacy and safety of preemptive therapy for cytomegalovirus end-organ disease in people living with HIV: a systematic review and meta-analysis

INTRODUCTION: Cytomegalovirus end-organ-disease (CMV EOD) is still a major cause of debilitating illness in people living with HIV, especially in developing countries. OBJECTIVE: To evaluate the efficacy and safety of preemptive therapy against CMV EOD in HIV-positive adults with CMV viremia. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Díaz-Brochero, Cándida, Nocua-Báez, Laura Cristina, Valderrama-Rios, Martha Carolina, Cortés, Jorge Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551618/
https://www.ncbi.nlm.nih.gov/pubmed/37777185
http://dx.doi.org/10.1016/j.bjid.2023.102805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551618/
https://www.ncbi.nlm.nih.gov/pubmed/37777185
http://dx.doi.org/10.1016/j.bjid.2023.102805

Ejemplares similares